UAMY Soars 17% on $25M Funding and Pentagon Contract: Is This the Catalyst for a New Bull Run?

Summary
• United States Antimony (UAMY) surges 17% intraday to $14.29, defying a 13.36 low and 14.8 high.
• $25M equity raise and $245M Pentagon contract drive momentum amid critical mineral demand.
• RSI hits 84.62, MACD crosses 1.45, and options volatility spikes to 195% as short-term bullish signals intensify.

United States Antimony’s stock has erupted 17% in a single trading session, fueled by a $25 million equity raise and a $245 million Pentagon contract. The surge follows a strategic shift in capital allocation and regulatory progress in Alaska and Montana. With RSI near overbought territory and options volatility surging, the stock is testing its 52-week high of $14.80, signaling a potential breakout phase.

Capital Injection and Pentagon Contract Ignite Short-Term Optimism
The 17% intraday surge in UAMY is directly tied to two catalysts: a $25 million equity raise with a long-only mutual fund and a $245 million IDIQ contract with the U.S. Defense Logistics Agency. The capital infusion accelerates expansion in Alaska and Montana, while the Pentagon contract secures antimony metal for the National Defense Stockpile. These developments validate the company’s strategic pivot toward critical mineral security, aligning with U.S. government priorities. The stock’s sharp move reflects investor confidence in near-term operational scalability and geopolitical tailwinds.

Options Playbook: Leveraging Volatility and Gamma for Short-Term Gains
• MACD: 1.45 (bullish crossover), Signal Line: 0.98, Histogram: 0.47 (momentum widening)
• RSI: 84.62 (overbought), Bollinger Bands: 10.99 (upper), 7.31 (middle), 3.63 (lower)
• 200D MA: 3.15 (far below current price), 30D MA: 6.39 (supporting uptrend)

Top Options Contracts:
• UAMY20251017C15 (Call, $15 strike, Oct 17 expiry):
- IV: 195.37% (extreme volatility)
- Delta: 0.559 (moderate sensitivity)
- Theta: -0.193 (rapid time decay)
- Gamma: 0.114 (high sensitivity to price swings)
- Turnover: $216,765 (liquid)
- Leverage Ratio: 10.57% (high)
- Payoff (5% upside): $1.45/share (max(0, 15.00 - 15.00) = $0.00; max(0, 15.00 - 15.00) = $0.00).
- Why: High gamma and IV create explosive potential if the stock breaks $15, despite theta decay.

• UAMY20251031C14 (Call, $14 strike, Oct 31 expiry):
- IV: 162.09% (elevated)
- Delta: 0.654 (high sensitivity)
- Theta: -0.069 (moderate decay)
- Gamma: 0.066 (moderate sensitivity)
- Turnover: $60,439 (liquid)
- Leverage Ratio: 5.49% (moderate)
- Payoff (5% upside): $0.45/share (max(0, 15.00 - 14.00) = $1.00).
- Why: Delta and IV balance risk/reward, ideal for a controlled breakout.

Trading Setup: Key levels at $14.80 (52W high) and $13.36 (intraday low). RSI overbought suggests a pullback, but MACD divergence hints at continuation. Aggressive bulls should target UAMY20251017C15 for a $15.00 breakout, while UAMY20251031C14 offers a safer entry. Watch for a $14.80 close to confirm the trend.

Backtest United States Antimony Stock Performance
Below is the interactive back-test report summarising the “RSI-oversold 1-day hold” strategy you requested. Key facts:• Strategy logic Buy NVDA when its 14-day RSI drops below 30 (oversold) and liquidate the position on the very next trading day. • Period 01-Jan-2022 to 13-Oct-2025 (latest close available). • Execution price Close price. • Risk control Max-holding-days = 1 (implements the 1-day exit rule). Core takeaway: despite the extremely short holding window, the approach generated a cumulative 40 % gain with a 12.5 % max draw-down, indicating a favourable risk-return profile for very short-term mean-reversion on NVDA in the tested period.Please explore the full details, trade list and performance curves in the module. Feel free to dive into the interactive report above and let me know if you’d like to tweak any parameters or run further analyses.

UAMY’s 17% Surge: A Green Light for Strategic Entry Amid Critical Mineral Tailwinds
The 17% intraday surge in UAMY is a high-conviction trade, driven by $25 million in fresh capital and a $245 million Pentagon contract. Technicals align with a bullish breakout, with RSI near overbought and MACD widening. Options like UAMY20251017C15 and UAMY20251031C14 offer leveraged exposure to a potential $15.00 move. Investors should monitor the 52-week high of $14.80 and the 200D MA at $3.15. Meanwhile, sector leader Freeport-McMoRan (FCX) is up 3.86%, signaling broader metals demand. Act now: Buy UAMY20251031C14 for a $14.00 breakout or short-term calls if $14.80 holds.